The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses

Shaun Andrew Summers, Richard Phoon, Joshua Ooi, Stephen Holdsworth, Arthur Kitching

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Despite its initially defined role as a T-helper type 1 cell (Th1)-inducing cytokine, interleukin-27 (IL-27) has complex roles in vivo. The role of IL-27 receptor (IL-27R) was defined in experimental crescentic glomerulonephritis induced by a foreign antigen, sheep globulin, which is planted in glomeruli. This lesion is dependent on a Th1 effector cellular response. Twenty-one days after the administration of sheep anti-mouse glomerular basement membrane antibody, wild-type mice developed histologic and functional inflammatory renal injury. Injury was attenuated in the absence of IL-27R I? chain (IL-27RI?), the unique component of the IL-27R complex. In contrast to the attenuated renal injury on day 21, Il27ra(-/-) mice exhibited enhanced systemic immune responses, including Th1 responses, with increased IL-2-dependent interferon-I? (IFN-I?) production. However, earlier in the development of the nephritogenic immune response, IFN-I? production was decreased, with reduced early immune responses translating into attenuated renal injury. Having demonstrated decreased early Th1 systemic immune responses, followed by enhanced nephritogenic Th1 immune responses, renal injury was studied at later time points. On days 28 and 35 after injection of the nephritogenic antigen, renal injury was enhanced in Il27ra(-/-) mice compared with wild-type mice in an at least partially IFN-I?-dependent manner. In Th1-dependent autoinflammatory lesions, IL-27RI? has a biphasic role in vivo, initially pathogenic, but ultimately playing a protective role by regulating immune responses and attenuating disease.
Original languageEnglish
Pages (from-to)580 - 590
Number of pages11
JournalAmerican Journal of Pathology
Volume178
Issue number2
DOIs
Publication statusPublished - 2011

Cite this

@article{89abc129fdea45a0862468f142a4710b,
title = "The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses",
abstract = "Despite its initially defined role as a T-helper type 1 cell (Th1)-inducing cytokine, interleukin-27 (IL-27) has complex roles in vivo. The role of IL-27 receptor (IL-27R) was defined in experimental crescentic glomerulonephritis induced by a foreign antigen, sheep globulin, which is planted in glomeruli. This lesion is dependent on a Th1 effector cellular response. Twenty-one days after the administration of sheep anti-mouse glomerular basement membrane antibody, wild-type mice developed histologic and functional inflammatory renal injury. Injury was attenuated in the absence of IL-27R I? chain (IL-27RI?), the unique component of the IL-27R complex. In contrast to the attenuated renal injury on day 21, Il27ra(-/-) mice exhibited enhanced systemic immune responses, including Th1 responses, with increased IL-2-dependent interferon-I? (IFN-I?) production. However, earlier in the development of the nephritogenic immune response, IFN-I? production was decreased, with reduced early immune responses translating into attenuated renal injury. Having demonstrated decreased early Th1 systemic immune responses, followed by enhanced nephritogenic Th1 immune responses, renal injury was studied at later time points. On days 28 and 35 after injection of the nephritogenic antigen, renal injury was enhanced in Il27ra(-/-) mice compared with wild-type mice in an at least partially IFN-I?-dependent manner. In Th1-dependent autoinflammatory lesions, IL-27RI? has a biphasic role in vivo, initially pathogenic, but ultimately playing a protective role by regulating immune responses and attenuating disease.",
author = "Summers, {Shaun Andrew} and Richard Phoon and Joshua Ooi and Stephen Holdsworth and Arthur Kitching",
year = "2011",
doi = "10.1016/j.ajpath.2010.10.013",
language = "English",
volume = "178",
pages = "580 -- 590",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "American Society for Investigative Pathology",
number = "2",

}

The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses. / Summers, Shaun Andrew; Phoon, Richard; Ooi, Joshua; Holdsworth, Stephen; Kitching, Arthur.

In: American Journal of Pathology, Vol. 178, No. 2, 2011, p. 580 - 590.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses

AU - Summers, Shaun Andrew

AU - Phoon, Richard

AU - Ooi, Joshua

AU - Holdsworth, Stephen

AU - Kitching, Arthur

PY - 2011

Y1 - 2011

N2 - Despite its initially defined role as a T-helper type 1 cell (Th1)-inducing cytokine, interleukin-27 (IL-27) has complex roles in vivo. The role of IL-27 receptor (IL-27R) was defined in experimental crescentic glomerulonephritis induced by a foreign antigen, sheep globulin, which is planted in glomeruli. This lesion is dependent on a Th1 effector cellular response. Twenty-one days after the administration of sheep anti-mouse glomerular basement membrane antibody, wild-type mice developed histologic and functional inflammatory renal injury. Injury was attenuated in the absence of IL-27R I? chain (IL-27RI?), the unique component of the IL-27R complex. In contrast to the attenuated renal injury on day 21, Il27ra(-/-) mice exhibited enhanced systemic immune responses, including Th1 responses, with increased IL-2-dependent interferon-I? (IFN-I?) production. However, earlier in the development of the nephritogenic immune response, IFN-I? production was decreased, with reduced early immune responses translating into attenuated renal injury. Having demonstrated decreased early Th1 systemic immune responses, followed by enhanced nephritogenic Th1 immune responses, renal injury was studied at later time points. On days 28 and 35 after injection of the nephritogenic antigen, renal injury was enhanced in Il27ra(-/-) mice compared with wild-type mice in an at least partially IFN-I?-dependent manner. In Th1-dependent autoinflammatory lesions, IL-27RI? has a biphasic role in vivo, initially pathogenic, but ultimately playing a protective role by regulating immune responses and attenuating disease.

AB - Despite its initially defined role as a T-helper type 1 cell (Th1)-inducing cytokine, interleukin-27 (IL-27) has complex roles in vivo. The role of IL-27 receptor (IL-27R) was defined in experimental crescentic glomerulonephritis induced by a foreign antigen, sheep globulin, which is planted in glomeruli. This lesion is dependent on a Th1 effector cellular response. Twenty-one days after the administration of sheep anti-mouse glomerular basement membrane antibody, wild-type mice developed histologic and functional inflammatory renal injury. Injury was attenuated in the absence of IL-27R I? chain (IL-27RI?), the unique component of the IL-27R complex. In contrast to the attenuated renal injury on day 21, Il27ra(-/-) mice exhibited enhanced systemic immune responses, including Th1 responses, with increased IL-2-dependent interferon-I? (IFN-I?) production. However, earlier in the development of the nephritogenic immune response, IFN-I? production was decreased, with reduced early immune responses translating into attenuated renal injury. Having demonstrated decreased early Th1 systemic immune responses, followed by enhanced nephritogenic Th1 immune responses, renal injury was studied at later time points. On days 28 and 35 after injection of the nephritogenic antigen, renal injury was enhanced in Il27ra(-/-) mice compared with wild-type mice in an at least partially IFN-I?-dependent manner. In Th1-dependent autoinflammatory lesions, IL-27RI? has a biphasic role in vivo, initially pathogenic, but ultimately playing a protective role by regulating immune responses and attenuating disease.

UR - http://www.ncbi.nlm.nih.gov/pubmed/21281790

U2 - 10.1016/j.ajpath.2010.10.013

DO - 10.1016/j.ajpath.2010.10.013

M3 - Article

VL - 178

SP - 580

EP - 590

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -